Literature DB >> 24469738

Myocardial perfusion MRI shows impaired perfusion of the mouse hypertrophic left ventricle.

Bastiaan J van Nierop1, Bram F Coolen, Noortje A Bax, Wouter J R Dijk, Elza D van Deel, Dirk J Duncker, Klaas Nicolay, Gustav J Strijkers.   

Abstract

There is growing consensus that myocardial perfusion deficits play a pivotal role in the transition from compensated to overt decompensated hypertrophy. The purpose of this study was to systematically study myocardial perfusion deficits in the highly relevant model of pressure overload induced hypertrophy and heart failure by transverse aortic constriction (TAC), which was not done thus far. Regional left ventricular (LV) myocardial perfusion (mL/min/g) was assessed in healthy mice (n = 6) and mice with TAC (n = 14). A dual-bolus first-pass perfusion MRI technique was employed to longitudinally quantify myocardial perfusion values between 1 and 10 weeks after surgery. LV function and morphology were quantified from cinematographic MRI. Myocardial rest perfusion values in both groups did not change significantly over time, in line with the essentially constant global LV function and mass. Myocardial perfusion was significantly decreased in TAC mice (4.2 ± 0.9 mL/min/g) in comparison to controls (7.6 ± 1.8 mL/min/g) (P = 0.001). No regional differences in perfusion were observed within the LV wall. Importantly, increased LV volumes and mass, and decreased ejection fraction correlated with decreased myocardial perfusion (P < 0.001, in all cases). Total LV blood flow was decreased in TAC mice (0.5 ± 0.1 mL/min, P < 0.001) in comparison to control mice (0.7 ± 0.2 mL/min). Myocardial perfusion in TAC mice was significantly reduced as compared to healthy controls. Perfusion was proportional to LV volume and mass, and related to decreased LV ejection fraction. Furthermore, this study demonstrates the potential of quantitative first-pass contrast-enhanced MRI for the study of perfusion deficits in the diseased mouse heart.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469738     DOI: 10.1007/s10554-014-0369-0

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  42 in total

Review 1.  Epidemiology, aetiology, and prognosis of heart failure.

Authors:  J J McMurray; S Stewart
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

2.  Why angina in aortic stenosis with normal coronary arteriograms?

Authors:  K Lance Gould; Blase A Carabello
Journal:  Circulation       Date:  2003-07-01       Impact factor: 29.690

3.  Prebolus quantitative MR heart perfusion imaging.

Authors:  Herbert Köstler; Christian Ritter; Michael Lipp; Meinrad Beer; Dietbert Hahn; Jörn Sandstede
Journal:  Magn Reson Med       Date:  2004-08       Impact factor: 4.668

Review 4.  The failing heart--an engine out of fuel.

Authors:  Stefan Neubauer
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

5.  Doppler estimation of reduced coronary flow reserve in mice with pressure overload cardiac hypertrophy.

Authors:  Craig J Hartley; Anilkumar K Reddy; Sridhar Madala; Lloyd H Michael; Mark L Entman; George E Taffet
Journal:  Ultrasound Med Biol       Date:  2008-02-06       Impact factor: 2.998

Review 6.  Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus.

Authors:  Bernard I Levy; Ernesto L Schiffrin; Jean-Jacques Mourad; Denis Agostini; Eric Vicaut; Michel E Safar; Harry A J Struijker-Boudier
Journal:  Circulation       Date:  2008-08-26       Impact factor: 29.690

7.  Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables.

Authors:  J Juenger; D Schellberg; S Kraemer; A Haunstetter; C Zugck; W Herzog; M Haass
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

8.  Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure.

Authors:  Srikanth Givvimani; Charu Munjal; Riyad Gargoum; Utpal Sen; Neetu Tyagi; Jonathan C Vacek; Suresh C Tyagi
Journal:  J Appl Physiol (1985)       Date:  2011-01-13

9.  Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.

Authors:  Gavin Y Oudit; Zamaneh Kassiri; Joyce Zhou; Qiao C Liu; Peter P Liu; Peter H Backx; Fayez Dawood; Michael A Crackower; James W Scholey; Josef M Penninger
Journal:  Cardiovasc Res       Date:  2008-02-15       Impact factor: 10.787

10.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

View more
  6 in total

Review 1.  Cardiovascular imaging 2014 in the International Journal of Cardiovascular Imaging.

Authors: 
Journal:  Int J Cardiovasc Imaging       Date:  2015-03       Impact factor: 2.357

2.  Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.

Authors:  Zhichao Zhou; Uthra Rajamani; Hicham Labazi; Stephen L Tilley; Catherine Ledent; Bunyen Teng; S Jamal Mustafa
Journal:  Purinergic Signal       Date:  2015-04-25       Impact factor: 3.765

3.  Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation.

Authors:  Vahagn Ohanyan; Liya Yin; Raffi Bardakjian; Christopher Kolz; Molly Enrick; Tatevik Hakobyan; John Kmetz; Ian Bratz; Jordan Luli; Masaki Nagane; Nadeem Khan; Huagang Hou; Periannan Kuppusamy; Jacqueline Graham; Frances Kwan Fu; Danielle Janota; Moses O Oyewumi; Suzanna Logan; Jonathan R Lindner; William M Chilian
Journal:  Circ Res       Date:  2015-07-29       Impact factor: 17.367

4.  Guidelines for measuring cardiac physiology in mice.

Authors:  Merry L Lindsey; Zamaneh Kassiri; Jitka A I Virag; Lisandra E de Castro Brás; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-05       Impact factor: 4.733

5.  Experimental animal models of coronary microvascular dysfunction.

Authors:  Oana Sorop; Jens van de Wouw; Selena Chandler; Vahagn Ohanyan; Johnathan D Tune; William M Chilian; Daphne Merkus; Shawn B Bender; Dirk J Duncker
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

6.  Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy.

Authors:  Shu-Huai Tsai; Guangrong Lu; Xin Xu; Yi Ren; Travis W Hein; Lih Kuo
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.